Target intelligence / Profile preview

Beaded filament structural protein 2 (BFSP2)

Target
BFSP2
Molecular classification
Intermediate filament, Type VI intermediate filament, Cytoskeletal protein, Other
01

Overview

Beaded filament structural protein 2 (BFSP2; also known as phakinin or CP49) is a lens-specific type VI intermediate filament protein critical for the development, transparency, and mechanical stability of the vertebrate ocular lens[1][2][3][4]. BFSP2 forms the beaded filament cytoskeleton in lens fiber cells by coassembling with filensin (BFSP1), a process essential for the correct packing and organization of differentiating fiber cells and for minimizing light scatter within the lens[2][3][6]. BFSP2 disruption, due to inherited mutations, results in aberrant fiber cell structure, compromised refractive architecture, increased light scatter, and cataract formation, commonly in pediatric or early adulthood onset[1][2][4]. The protein does not function as a receptor, enzyme, transporter, or druggable target but is necessary for cytoskeletal integrity in lens tissues. Currently, no drugs are known to target BFSP2 directly; its main clinical relevance is as a structural protein whose mutations provide a genetic risk biomarker for opacity-related lens diseases[1][3][4].

Other names
CP49PhakininCP47LIFL-LPHAKOSINCTRCT1249 kDa cytoskeletal proteinlens fiber cell beaded filament protein CP 47lens fiber cell beaded filament protein CP 49lens intermediate filament-like lightbeaded filament protein CP49beaded filament structural protein 2
02

Biological functions

Structural constituent of lens fiber cell cytoskeletonMaintenance of lens transparencyOrganization of lens fiber cell architectureLens biomechanical integrity
03

Disease associations

Cataract (multiple types, especially juvenile/early onset)Dowling-Meara epidermolysis bullosa simplex (rare association)Myopia associated with specific allelic formsOther (implicated in lens aging and degeneration)
04

Biomarkers

Mutations in BFSP2 serve as genetic biomarkers for early-onset cataract susceptibility[1][3].

Beyond the preview

Go deeper on Beaded filament structural protein 2 (BFSP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beaded filament structural protein 2 (BFSP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call